May 28, 2024
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Arcutis treatment helps deliver Q1 earnings beat

IN THIS ARTICLE

Shares of Westlake Village-based Arcutis Biotherapeutics shot up 13% on May 15, one day the company announced its earnings results for the first quarter that beat analysts' expectations. Arcutis, a biotechnology company specializing in developing drugs for immune dermatological conditions, generated total revenue worth $49.9 million in the first quarter of 2024, up $47 million from the…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.